Back

X-Linked Cancer-Associated Polypeptide (XCP) from lncRNA1456 Cooperates with PHF8 to Regulate Gene Expression and Cellular Pathways in Breast Cancer

Gadad, S.; Camacho, C. V.; Gong, X.; Thornton, M.; Malladi, V. S.; Nagari, A.; Sundaresan, A.; Nandu, T.; Koul, S.; Peng, Y.; Kraus, W. L.

2025-03-25 cancer biology
10.1101/2025.03.21.644649 bioRxiv
Show abstract

Recent studies have demonstrated that a subset of long "noncoding" RNAs (lncRNAs) produce functional polypeptides and proteins. In this study, we discovered a 132 amino acid protein in human breast cancer cells named XCP (X-linked Cancer-associated Polypeptide), which is encoded by lncRNA1456 (a.k.a. RHOXF1P3), a transcript previously thought to be noncoding. lncRNA1456 is a pancreas- and testis-specific RNA whose gene is located on chromosome X. We found that the expression of lncRNA1456 and XCP are highly upregulated in the luminal A, luminal B, and HER2 molecular subtypes of breast cancer. XCP modulates both estrogen-dependent and estrogen-independent growth of breast cancer cells by regulating cancer pathways, as shown in cell and xenograft models. XCP shares some homology with homeodomain-containing proteins and interacts with the histone demethylase plant homeodomain finger protein 8 (PHF8), which is also encoded by an X-linked gene. Mechanistically, XCP stimulates the histone demethylase activity of PHF8 to regulate gene expression in breast cancer cells. These findings identify XCP as a coregulator of transcription and emphasize the need to interrogate the potential functional roles of open reading frames originating from noncoding RNAs. Statement of SignificangeXCP, a polypeptide encoded by an X-linked lncRNA, regulates gene expression in breast cancer cells. XCP is a chromatin-associated protein that interacts with the histone demethylase PHF8 and modulates its demethylase activity to regulate gene expression. XCP drives cancer-specific phenotypes and serves as a potential biomarker and/or target for therapeutic intervention.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Oncogene
85 papers in training set
Top 0.1%
30.2%
2
eLife
5828 papers in training set
Top 20%
6.1%
3
Cell Reports
1498 papers in training set
Top 6%
6.1%
4
Nature Communications
5641 papers in training set
Top 30%
4.7%
5
Molecular Cancer Research
49 papers in training set
Top 0.2%
4.2%
50% of probability mass above
6
iScience
1154 papers in training set
Top 7%
3.2%
7
Science Advances
1243 papers in training set
Top 11%
3.1%
8
Cancer Research
130 papers in training set
Top 1%
3.1%
9
Communications Biology
993 papers in training set
Top 11%
2.1%
10
PLOS Genetics
862 papers in training set
Top 7%
1.9%
11
Cancer Research Communications
51 papers in training set
Top 0.9%
1.7%
12
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 29%
1.7%
13
Nucleic Acids Research
1281 papers in training set
Top 10%
1.5%
14
Scientific Reports
3612 papers in training set
Top 61%
1.4%
15
Redox Biology
70 papers in training set
Top 0.8%
1.4%
16
Breast Cancer Research
36 papers in training set
Top 0.4%
1.3%
17
Cells
249 papers in training set
Top 4%
1.3%
18
Genome Biology
637 papers in training set
Top 7%
1.1%
19
NAR Cancer
37 papers in training set
Top 0.5%
1.1%
20
PLOS ONE
5266 papers in training set
Top 56%
1.1%
21
Mobile DNA
31 papers in training set
Top 0.2%
1.0%
22
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.6%
1.0%
23
Genome Research
468 papers in training set
Top 6%
1.0%
24
BMC Cancer
67 papers in training set
Top 2%
0.8%
25
Journal of Biological Chemistry
690 papers in training set
Top 10%
0.8%
26
Genome Medicine
183 papers in training set
Top 5%
0.8%
27
Epigenetics & Chromatin
42 papers in training set
Top 0.6%
0.8%
28
Cell Communication and Signaling
51 papers in training set
Top 2%
0.6%
29
Cancer Gene Therapy
11 papers in training set
Top 0.2%
0.6%
30
Theranostics
37 papers in training set
Top 1%
0.6%